Live Breaking News & Updates on Valiant navion

Stay informed with the latest breaking news from Valiant navion on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Valiant navion and stay connected to the pulse of your community

Medtronic (MDT) Q3 2022 Earnings Call Transcript

MDT earnings call for the period ending December 31, 2021.

Australia , Japan , United-states , India , Israel , China , Minnesota , Chile , Canada , Panama , America , American

Medtronic Reports Second Quarter Fiscal 2022 Financial Results

/PRNewswire/ -- Medtronic plc (NYSE:MDT) today announced financial results for its second quarter of fiscal year 2022, which ended October 29, 2021. Key...

Dublin , Ireland , Australia , Japan , United-states , New-zealand , Canada , America , Erika-winkels , Ryan-weispfenning , Geoff-martha , Karen-parkhill

Medtronic Reports Second Quarter Fiscal 2022 Financial Results

/PRNewswire/ -- Medtronic plc (NYSE:MDT) today announced financial results for its second quarter of fiscal year 2022, which ended October 29, 2021. Key...

Dublin , Ireland , Australia , Japan , United-states , New-zealand , Canada , America , Erika-winkels , Ryan-weispfenning , Geoff-martha , Karen-parkhill

Medtronic Reports First Quarter Fiscal 2022 Financial Results

Medtronic Reports First Quarter Fiscal 2022 Financial Results
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

China , Australia , Japan , United-states , New-zealand , Ireland , Dublin , Canada , America , Erika-winkels , Ryan-weispfenning , Geoff-martha

Medtronic Reports First Quarter Fiscal 2022 Financial Results

Medtronic Reports First Quarter Fiscal 2022 Financial Results
investingnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investingnews.com Daily Mail and Mail on Sunday newspapers.

China , Australia , Japan , United-states , New-zealand , Ireland , Dublin , Canada , America , Erika-winkels , Ryan-weispfenning , Geoff-martha

Medtronic's recall of unsterilized angiography guidewires labeled Class I event by FDA

Medtronic's recall of unsterilized angiography guidewires labeled Class I event by FDA
medtechdive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medtechdive.com Daily Mail and Mail on Sunday newspapers.

California , United-states , New-york , Oklahoma , Australia , Louisiana , Nebraska , Texas , Washington , Kentucky , Wisconsin , Ohio

Medtronic Reports Fourth Quarter and Fiscal Year 2021 Financial Results; Announces 9% Dividend Increase

Medtronic Reports Fourth Quarter and Fiscal Year 2021 Financial Results; Announces 9% Dividend Increase
- Q4 Revenue of $8.2 Billion Increased 37% Reported and 32% Organic
- Q4 GAAP Diluted EPS of $1.00; Q4 Non-GAAP Diluted EPS of $1.50
- Quarterly Dividend Increased to $0.63, Annual $2.52 from Prior $2.32; 44th Consecutive Year of Dividend Increases
- Company Issues FY22 Guidance
- Guidance Reflects FY22 Revenue Growth above Street Consensus, Investment Ahead of Major Product Launches, and Largest Planned R&D Increase in Company History
News provided by
Share this article
Share this article
DUBLIN, May 27, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT) today announced financial results for its fourth quarter and fiscal year 2021, which ended April 30, 2021. The company reported fourth quarter worldwide revenue of $8.188 billion, an increase of 37 percent as reported and 32 percent on an organic basis, which adjusts for the $241 million benefit of foreign currency translation. The company's fourth quarter results reflect a strong recovery from the impact of the COVID-19 pandemic on elective procedures that the company experienced in April 2020. Unless otherwise stated, all quarterly revenue growth rates in this press release are stated on an organic basis, which adjusts for the impact of foreign currency translation.

United-states , Dublin , Ireland , Erika-winkels , Ryan-weispfenning , Geoff-martha , Karen-parkhill , Restorative-therapies-group , Pelvic-health , Exchange-commission , Peripheral-vascular-health , Ablation-solutions

Medtronic PLC (MDT) Q4 2021 Earnings Call Transcript

MDT earnings call for the period ending April 30, 2021.

China , Boston , Massachusetts , United-states , Japan , India , Canada , Brazil , Stealthstation-flex , Ryan-weispfenning , Geoff-martha , Karenl-parkhill

FDA Names Recall of Valiant Navion Stent Graft as Class I

FDA Names Recall of Valiant Navion Stent Graft as Class I
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.

Drug-administration , Medtronic , Valiant-navion , மெதிடிறோனிக் ,

Medtronic Recalls Unused Valiant Navion Thoracic Stent Graft System

Medtronic Recalls Unused Valiant Navion Thoracic Stent Graft System
FRIDLEY (dpa-AFX) - Medtronic plc has recalled unused Medtronic Valiant Navion thoracic stent graft system globally, according to the U.S. Food and Drug Administration. The Irish medical technology company also informed physicians to immediately cease use of the device until further notice.
The company initiated the recall following information obtained from the Valiant Evo Global Clinical Trial indicating that three patients in the trial were observed to have stent fractures, two of which have confirmed type IIIb endoleaks. One patient death was reported.
Following these observations, an independent imaging laboratory reviewed all available images from patients enrolled in the Valiant Evo Global Clinical Trial. It was found that seven out of 87 patients were observed to have stent ring enlargement beyond the design specification. Those observations require further assessment to determine potential clinical importance.

Ireland , Irish , Drug-administration , Medtronic , Medtronic-valiant-navion , Valiant-evo-global-clinical-trial , Valiant-evo-global-clinical , Valiant-navion , Recalls , Unused , Valiant